Skip to content
Search

Latest Stories

RPS Scotland welcomes Cabinet Secretary’s commitment to achieving protected learning time for health professionals

The Royal Pharmaceutical Society (RPS) Director (RPS Scotland) Clare Morrison participated in the panel discussion alongside representatives from other health professional organizations on tackling the workforce crisis at the SNP conference in Aberdeen on 8 October.

At the conference, the Cabinet Secretary for Health and Social Care committed to achieving protected learning time for health professionals. Morrison welcomed the Cabinet Secretary's statement as fantastic news for pharmacists across Scotland.


RPS Scotland will follow up the discussion by writing to the Cabinet Secretary to request a meeting to discuss achieving protected learning time, the forthcoming results of our workforce wellbeing survey, and positive examples of how pharmacy teams have improved the well-being of their teams,” said the society.

Clare described the positive recent expansions of pharmacists' roles, such as the development of NHS Scotland's Pharmacy First and Pharmacy First Plus services which have transformed independent prescribing in community pharmacy, and the Pharmacotherapy Service which embedded pharmacy teams in general practice.

However, she cautioned that these services had been introduced without proper pharmacy workforce planning. She went on that although it was great to see such pharmacy services described in the current Scottish Government winter resilience plan, the plan lacked commitments on recruitment and retention of pharmacists.

"We know there are shortages of pharmacists across every sector of pharmacy - hospital community and general practice. We need Scottish Government to undertake workforce planning for pharmacy in the way it does for doctors and nurses," she said at the event.

Clare stressed the need to increase the pharmacy workforce but said short term actions are needed right now to retain the existing workforce. She highlighted ways to improve well-being such as mandating rest breaks (which are essential for both the welfare of pharmacists and for patient safety), enabling flexible working and portfolio careers, and protected learning time.

"I was absolutely delighted that the Cabinet Secretary said he is committed to achieving protected learning time and recognizes its importance," Clare said.

Also discussed were ways to make existing work processes more efficient. Clare suggested better sharing of patient data, speeding up the introduction of electronic prescribing and dispensing, automation and robotics, and better use of skill mix.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less